MTNB Stock Summary and Trading Ideas (Matinas Biopharma Hldgs | AMEX:MTNB)

Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm's pipeline includes MAT2203, MAT2501, and others. Its LNC platform enables safe, intracellular, oral- delivery of small molecules and small oligonucleotides.

Matinas Biopharma Hldgs trades on the AMEX stock market under the symbol MTNB.

As of November 5, 2026, MTNB stock price declined to $1.16 with 57,308 million shares trading.

MTNB has a beta of 1.45, meaning it tends to be more sensitive to market movements. MTNB has a correlation of 0.00 to the broad based SPY ETF.

MTNB has a market cap of $17.04 million. This is considered a Sub-Micro Cap stock.

In the last 3 years, MTNB traded as high as $4.49 and as low as $.09.

The top ETF exchange traded funds that MTNB belongs to (by Net Assets): VXF.

MTNB has underperformed the market in the last year with a price return of +2.5% while the SPY ETF gained +9.3%. However, in the short term, MTNB had mixed performance relative to the market. It has outperformed in the last 3 months, returning +321.8% vs -4.5% return in SPY. But in the last 2 weeks, MTNB shares have been beat by the market, returning -32.2% compared to an SPY return of -4.1%.

MTNB support price is $1.05 and resistance is $1.33 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that MTNB shares will trade within this expected range on the day.